A nurse is collecting data from a client who has a respiratory disorder and displays manifestations of hypoxia. Which of the following findings should the nurse expect?

A. Bradypnea, or abnormally slow breathing, is not typically associated with hypoxia. Hypoxia usually triggers an increase in respiratory rate (tachypnea) as the body attempts to take in more oxygen to meet its needs.
B. Cyanosis, a bluish discoloration of the skin and mucous membranes, is a key sign of hypoxia. It occurs when there is insufficient oxygen in the blood, leading to a darker color of deoxygenated hemoglobin. Cyanosis is most commonly observed in the lips, fingertips, and toes.
C. Pallor, or paleness of the skin, can occur in various conditions but is not specific to hypoxia. It is more commonly associated with anemia or shock rather than low oxygen levels in the blood.
D. Bradycardia, or a slower-than-normal heart rate, is not typically a manifestation of hypoxia. Instead, hypoxia often causes tachycardia as the body attempts to increase oxygen delivery to tissues by pumping blood more quickly.

A. BNP does not promote the synthesis of angiotensin II; instead, it counteracts the effects of the renin-angiotensin-aldosterone system (RAAS) by reducing fluid retention and blood pressure, which is the opposite of what angiotensin II does.
B. BNP does not increase heart rate or cardiac contractility. Its role is primarily in reducing cardiac workload by lowering blood pressure and decreasing fluid volume.
C. BNP does not increase blood pressure; rather, it acts to decrease it by causing vasodilation and inhibiting the effects of aldosterone, which would otherwise increase blood pressure by promoting sodium and water retention.
D. BNP decreases blood pressure by causing vasodilation and promoting the excretion of sodium and water, which reduces blood volume and, consequently, lowers the blood pressure. This is its primary role in cardiovascular regulation, especially in response to heart failure.